Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1356.27
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 22-May-2026
NAV [Rs.]
: 25.205
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.38 | 10.91 | 10.8 | 10.36 | 15.14 | 27.59 | - | 12.44 |
| Category Avg | -0.45 | -1.22 | -1.79 | 1.4 | 15.56 | 17.51 | 12.45 | 13.2 |
| Category Best | 6.07 | 14.07 | 26.94 | 74.9 | 166.97 | 52.87 | 33.01 | 163.86 |
| Category Worst | -7.73 | -10.84 | -16.94 | -82.7 | -20.94 | 2.23 | 4.01 | -23.32 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 22.53 | 1689972 | 305.59 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.73 | 202900 | 131.93 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.49 | 972549 | 128.65 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 8.67 | 898106 | 117.61 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.58 | 387240 | 89.26 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.15 | 166937 | 69.86 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 5.04 | 621030 | 68.37 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.57 | 446204 | 62.00 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 4.27 | 240403 | 57.84 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.71 | 93305 | 50.38 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.02 | 1139335 | 40.97 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.99 | 180640 | 40.58 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.63 | 399366 | 35.61 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.50 | 221604 | 33.92 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.97 | 130726 | 26.71 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.64 | 127093 | 22.25 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.55 | 8285 | 21.07 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.40 | 67273 | 18.98 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.36 | 131738 | 18.38 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.18 | 989174 | 16.01 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,40,030.99
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
